메뉴 건너뛰기




Volumn 61, Issue 11, 2013, Pages 1146-1156

Extreme lipoprotein(a) levels and improved cardiovascular risk prediction

Author keywords

Coronary heart disease; Lipoprotein(a); Risk prediction

Indexed keywords

LIPOPROTEIN A;

EID: 84877155652     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.12.023     Document Type: Article
Times cited : (236)

References (27)
  • 1
    • 77954312278 scopus 로고    scopus 로고
    • Lipoprotein(a) and ischemic heart disease - A causal association?
    • Kamstrup PR. Lipoprotein(a) and ischemic heart disease-a causal association? A review. Atherosclerosis 2010;211:15-23.
    • (2010) A Review. Atherosclerosis , vol.211 , pp. 15-23
    • Kamstrup, P.R.1
  • 2
    • 78649888517 scopus 로고    scopus 로고
    • Lipoprotein(a) as a cardiovascular risk factor: Current status
    • Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010;31: 2844 -53.
    • (2010) Eur Heart J , vol.31 , pp. 2844-2853
    • Nordestgaard, B.G.1    Chapman, M.J.2    Ray, K.3
  • 4
    • 67651210632 scopus 로고    scopus 로고
    • Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
    • Erqou S, Kaptoge S, Perry PL, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009;302:412-23.
    • (2009) JAMA , vol.302 , pp. 412-423
    • Erqou, S.1    Kaptoge, S.2    Perry, P.L.3
  • 5
    • 33748904095 scopus 로고    scopus 로고
    • Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women
    • Danik JS, Rifai N, Buring JE, Ridker PM. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 2006;296:1363-70.
    • (2006) JAMA , vol.296 , pp. 1363-1370
    • Danik, J.S.1    Rifai, N.2    Buring, J.E.3    Ridker, P.M.4
  • 6
    • 38049177286 scopus 로고    scopus 로고
    • Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: The Copenhagen City Heart Study
    • Kamstrup PR, Benn M, Tybjærg-Hansen A, Nordestgaard BG. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 2008;117:176-84.
    • (2008) Circulation , vol.117 , pp. 176-184
    • Kamstrup, P.R.1    Benn, M.2    Tybjrg-Hansen, A.3    Nordestgaard, B.G.4
  • 7
    • 3242780945 scopus 로고    scopus 로고
    • Apolipoprotein(a) size and lipoprotein( a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study
    • Rifai N, Ma J, Sacks FM, et al. Apolipoprotein(a) size and lipoprotein( a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study. Clin Chem 2004;50:1364 -71.
    • (2004) Clin Chem , vol.50 , pp. 1364-1371
    • Rifai, N.1    Ma, J.2    Sacks, F.M.3
  • 8
    • 67049167090 scopus 로고    scopus 로고
    • Genetically elevated lipoprotein(a) and increased risk of myocardial infarction
    • Kamstrup PR, Tybjærg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009;301:2331-9.
    • (2009) JAMA , vol.301 , pp. 2331-2339
    • Kamstrup, P.R.1    Tybjærg-Hansen, A.2    Steffensen, R.3    Nordestgaard, B.G.4
  • 9
    • 73549097512 scopus 로고    scopus 로고
    • Genetic variants associated with Lp(a) lipoprotein level and coronary disease
    • Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009;361:2518 -28.
    • (2009) N Engl J Med , vol.361 , pp. 2518-2528
    • Clarke, R.1    Peden, J.F.2    Hopewell, J.C.3
  • 10
    • 8844246477 scopus 로고    scopus 로고
    • Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    • Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 2004;24:e149-e161.
    • (2004) Arterioscler Thromb Vasc Biol , vol.24
    • Grundy, S.M.1    Cleeman, J.I.2    Merz, C.N.3
  • 11
    • 79960539641 scopus 로고    scopus 로고
    • ESC/EAS guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
    • Reiner Z, Catapano AL, De BG, et al. ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32: 1769 - 818.
    • (2011) Eur Heart J , vol.32 , pp. 1769-1818
    • Reiner, Z.1    Catapano, A.L.2    De, B.G.3
  • 12
    • 84862502750 scopus 로고    scopus 로고
    • Lipid-related markers and cardiovascular disease prediction
    • Angelantonio E, Gao P, Pennells L, et al. Lipid-related markers and cardiovascular disease prediction. JAMA 2012;307:2499 -506.
    • (2012) JAMA , vol.307 , pp. 2499-2506
    • Angelantonio, E.1    Gao, P.2    Pennells, L.3
  • 13
    • 78650041424 scopus 로고    scopus 로고
    • 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:e50 -103.
    • (2010) J Am Coll Cardiol , vol.56
    • Greenland, P.1    Alpert, J.S.2    Beller, G.A.3
  • 14
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
    • Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr., Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72.
    • (2008) Stat Med , vol.27 , pp. 157-172
    • Pencina, M.J.1    D'Agostino Sr., R.B.2    D'Agostino Jr., R.B.3    Vasan, R.S.4
  • 15
    • 0002697048 scopus 로고    scopus 로고
    • Lipoprotein(a)
    • Scriver CR, Sly WS, Childs B, et al., editors New York, NY: McGraw-Hill, Medical Publishing Division
    • Utermann G. Lipoprotein(a). In: Scriver CR, Sly WS, Childs B, et al., editors. Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill, Medical Publishing Division, 2001: 2753- 87.
    • (2001) Metabolic and Molecular Bases of Inherited Disease , pp. 2753-2787
    • Utermann, G.1
  • 16
    • 85027946492 scopus 로고    scopus 로고
    • Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis
    • Kamstrup PR, Tybjærg-Hansen A, Nordestgaard BG. Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis. Arterioscler Thromb Vasc Biol 2012;32:1732-41.
    • (2012) Arterioscler Thromb Vasc Biol , vol.32 , pp. 1732-1741
    • Kamstrup, P.R.1    Tybjærg-Hansen, A.2    Nordestgaard, B.G.3
  • 17
    • 0033554451 scopus 로고    scopus 로고
    • Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: Prospective results from the Bruneck study
    • Kronenberg F, Kronenberg MF, Kiechl S, et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 1999;100:1154-60.
    • (1999) Circulation , vol.100 , pp. 1154-1160
    • Kronenberg, F.1    Kronenberg, M.F.2    Kiechl, S.3
  • 18
    • 0033664654 scopus 로고    scopus 로고
    • High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men
    • Paultre F, Pearson TA, Weil HF, et al. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol 2000;20:2619 -24.
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 2619-2624
    • Paultre, F.1    Pearson, T.A.2    Weil, H.F.3
  • 19
    • 0002458476 scopus 로고    scopus 로고
    • Sterbroundersøgelsen. Tables with data from the third examination, 1991-1994
    • The Copenhagen City Heart Study
    • Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study. Østerbroundersøgelsen. Tables with data from the third examination, 1991-1994. Eur Heart J 2001;3:H1-83.
    • (2001) Eur Heart J , vol.3
    • Schnohr, P.1    Jensen, G.2    Lange, P.3    Scharling, H.4    Appleyard, M.5
  • 20
    • 0033567222 scopus 로고    scopus 로고
    • Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies
    • Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999;150:341-53.
    • (1999) Am J Epidemiol , vol.150 , pp. 341-353
    • Clarke, R.1    Shipley, M.2    Lewington, S.3
  • 21
    • 0024466520 scopus 로고
    • Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid
    • Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 1989;226:271- 6.
    • (1989) J Intern Med , vol.226 , pp. 271-276
    • Carlson, L.A.1    Hamsten, A.2    Asplund, A.3
  • 22
    • 0027503266 scopus 로고
    • Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study
    • Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation 1993;87:1135- 41.
    • (1993) Circulation , vol.87 , pp. 1135-1141
    • Jenner, J.L.1    Ordovas, J.M.2    Lamon-Fava, S.3
  • 23
    • 84921702413 scopus 로고    scopus 로고
    • Interaction revisited: The difference between two estimates
    • Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326:219.
    • (2003) BMJ , vol.326 , pp. 219
    • Altman, D.G.1    Bland, J.M.2
  • 24
    • 0024998126 scopus 로고
    • Prognostic scores for detecting a high risk group: Estimating the sensitivity when applied to new data
    • Phillips AN, Thompson SG, Pocock SJ. Prognostic scores for detecting a high risk group: estimating the sensitivity when applied to new data. Stat Med 1990;9:1189 -98.
    • (1990) Stat Med , vol.9 , pp. 1189-1198
    • Phillips, A.N.1    Thompson, S.G.2    Pocock, S.J.3
  • 26
    • 29844453811 scopus 로고    scopus 로고
    • Efficient calculation of jackknife confidence intervals for rank statistics
    • Newson R. Efficient calculation of jackknife confidence intervals for rank statistics. J Stat Soft 2006;15:1-10.
    • (2006) J Stat Soft , vol.15 , pp. 1-10
    • Newson, R.1
  • 27
    • 77957671687 scopus 로고    scopus 로고
    • Comparing the predictive powers of survival models using Harrell's C or Somers' D
    • Newson R. Comparing the predictive powers of survival models using Harrell's C or Somers' D. The Stata Journal 2010;10:339 -58.
    • (2010) The Stata Journal , vol.10 , pp. 339-358
    • Newson, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.